BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang ZG, Chen Z, Ni Q, Xu N, Shao JB, Yao HP. Inhibition of hepatitis B virus surface antigen expression by small hairpin RNA in vitroWorld J Gastroenterol 2005; 11(4): 498-502 [PMID: 15641133 DOI: 10.3748/wjg.v11.i4.498]
URL: https://www.wjgnet.com/2218-6247/full/v11/i4/498.htm
Number Citing Articles
1
D Grimm, M A Kay. Therapeutic short hairpin RNA expression in the liver: viral targets and vectorsGene Therapy 2006; 13(6): 563 doi: 10.1038/sj.gt.3302727
2
Yong Chen, Guofeng Cheng, Ram I. Mahato. RNAi for Treating Hepatitis B Viral InfectionPharmaceutical Research 2008; 25(1): 72 doi: 10.1007/s11095-007-9504-0
3
Rui-Hua Guo, Quan Zhang, Yun-Bao Ma, Jie Luo, Chang-An Geng, Li-Jun Wang, Xue-Mei Zhang, Jun Zhou, Zhi-Yong Jiang, Ji-Jun Chen. Structure–activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agentsEuropean Journal of Medicinal Chemistry 2011; 46(1): 307 doi: 10.1016/j.ejmech.2010.11.019
4
Ray K.M. Leung, Paul A. Whittaker. RNA interference: From gene silencing to gene-specific therapeuticsPharmacology & Therapeutics 2005; 107(2): 222 doi: 10.1016/j.pharmthera.2005.03.004
5
Fang Jia, Yi-Zheng Zhang, Chang-Mei Liu. Stable inhibition of hepatitis B virus expression and replication in HepG2.2.15 cells by RNA interference based on retrovirus deliveryJournal of Biotechnology 2007; 128(1): 32 doi: 10.1016/j.jbiotec.2006.09.007
6
L Garcia-Rodríguez, D Abate-Daga, A Rojas, J R González, C Fillat. E-cadherin contributes to the bystander effect of TK/GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer modelsGene Therapy 2011; 18(1): 73 doi: 10.1038/gt.2010.114